X0306 4 2020-02-12 false 0001597553 Sage Therapeutics, Inc. SAGE 0001042021 JONAS JEFFREY M C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 true true false false President & CEO Stock Option (Right to Buy) 68.87 2020-02-12 4 A false 50000.00 0.00 A 2030-02-12 Common Stock 50000.00 50000.00 D The securities awarded on February 12, 2020 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 12,500 shares of common stock shall vest on the one year anniversary of February 12, 2020, with 37,500 shares vesting in 36 equal monthly installments thereafter. /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Jeffrey M. Jonas 2020-02-14